1.
SERUM CYSTATIN C FOR RISK STRATIFICATION IN PATIENTS WITH PREDIABETES. MSU [Internet]. 2025 Jun. 28 [cited 2026 Apr. 8];4(3):122-6. Available from: https://www.fdoctors.uz/index.php/journal/article/view/173